Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients - evidence from a large observational cohort

Affiliations

• ¹ a University of Bari "Aldo Moro", Clinic of Infectious Diseases , Bari , Italy.
• ² b Pediatric Clinical Research Center "Romeo and Enrica Invernizzi" University of Milan , Milan , Italy.
• ³ c Department of Biology and Biotechnology , University of Pavia , Pavia , Italy.
• ⁴ d Department of Public Health and Infectious Diseases , Italy "Sapienza" University of Rome , Rome , Italy.
• ⁵ e Department of Health Sciences , University of Milan, "San Paolo" Hospital, ASST "Santi Paolo e Carlo", Clinic of Infectious Diseases , Milan , Italy.
• ⁶ f EuResist Network GEIE , Rome , Italy.
• ⁷ g InformaPRO S.r.l , Rome , Italy.
• ⁸ h Experimental Medicine and Surgery, University of Rome "Tor Vergata" , Rome , Italy.
• ⁹ i SOD Infectious and Tropical Diseases, AOU CAREGGI , Florence , Italy.
• ¹⁰ j "Cattolica" Virology Laboratory , Rome , Italy.
• ¹¹ k Institute of Clinical Infectious Diseases "Cattolica" , Rome , Italy.
• ¹² l Polyclinic of Modena , Modena , Italy.
• ¹³ m Department of Medical Biotechnologies , University of Siena , Siena , Italy.